Parent Project Muscular Dystrophy and Sarepta Therapeutics hosted a webinar on November 24, 2020 for a discussion about the SRP-9001 gene therapy development program. * This webinar recording contains edits to content requested by the company. Research & Clinical Trial Webinars,Webinars 4 years ago You may also like 58:17 Summit’s Utrophin Modulation Program (January 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 1:00:21 Vamorolone (VBP15) Clinical Trials in Duchenne (January 2017) 8 years ago Research & Clinical Trial Webinars,Webinars 1:04:29 A Closer Look at the Potential of CRISPR/Cas9 in Duchenne (December 2016) 8 years ago Research & Clinical Trial Webinars,Webinars gene therapy 43:10 NS Pharma’s Exon 53 Skipping Program (November 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 47:28 Community Update Call: Sarepta & Summit (October 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 47:33 SareptAssist Patient Services Overview (September 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 1:24:01 PTC Therapeutics Provides Regulatory Update on Translarna (August 2016) 8 years ago Research & Clinical Trial Webinars,Webinars 1:00:59 What is CRISPR/Cas9? (July 2016) 8 years ago Research & Clinical Trial Webinars,Webinars gene therapy «1…1920212223…26»Page 21 of 26
by: Parent Project Muscular Dystrophy
